Doctor HQ | healthcare headquarters

FDA Approves New Opioid for Intravenous Use in Hospitals, Other Controlled Clinical Settings
Coronavirus (COVID-19) Update: Daily Roundup August 7, 2020
FDA Approves First Liquid Biopsy Next-Generation Sequencing Companion Diagnostic Test
FDA Approves Oral Treatment for Spinal Muscular Atrophy
Coronavirus (COVID-19) Update: Daily Roundup August 6, 2020

SC nears 100,000 confirmed coronavirus cases and 2,000 reported deaths
10,000 dead of coronavirus in California. 100 dead in its capital. How did we get here?
Texas Surpasses 500k COVID-19 Cases, 7-Day Avg Positivity Rate of 20.3%
Bill Gates: US only country to have coronavirus 'testing insanity'
Vancouver bar manager stops large group of party bus riders from entering bar

Small farmers left behind in Trump administration’s COVID-19 relief package
Nine people test positive for coronavirus at Georgia school captured in viral images
Trump’s pandemic relief orders are limited in scope
Mexico surpasses 480,000 total coronavirus cases
Over 350 cars stopped at NYC ‘quarantine checkpoints’ during first three days

Travel during the COVID-19 Pandemic ' CDC
Donate Blood Plasma and Help Save Lives
eCR Now: COVID-19 Electronic Case Reporting
Operational Considerations for Maintaining Essential Services for and Providing Maternal, Newborn, and Child Healthcare in Low-Resource Countries
Interim Operational Considerations for Implementing the Shielding Approach to Prevent COVID-19 Infections in Humanitarian Settings

Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis.
Renin-Angiotensin II-Aldosterone Axis in SARS-CoV-2 Associated Xerostomia.
Susceptibility to COVID-19 in patients treated with antimalarials: a population based study in Emilia-Romagna, Northern Italy.
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study.

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19
Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19
P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19

Children's Anxiety and Physical Activity during COVID-19 in Relation to Prenatal Exposure to Gestational Diabetes
The effect of school closures and reopening strategies on COVID-19 infection dynamics in the San Francisco Bay Area: a cross-sectional survey and modeling analysis
Obtaining prevalence estimates of COVID-19: A model to inform decision-making
Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: a nationwide cohort study
Single-cell RNA-seq reveals profound monocyte changes in Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 infection (PIMS-TS)

Susceptibility to COVID-19 in patients treated with antimalarials: a population based study in Emilia-Romagna, Northern Italy.
Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study.
Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report.
Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study.
Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.

Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting
Therapeutics for Inpatients With COVID-19
Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan
Adaptive COVID-19 Treatment Trial 3 (ACTT-3)
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Mais 240 pessoas recuperadas nas últimas 24 horas
Rede Nacional de Cuidados Continuados Integrados regista apenas um caso de COVID-19
Mais 4300 profissionais de saúde reforçaram SNS em tempo de pandemia
Validação por SMS
Mais 247 doentes recuperados e menos internamentos nas últimas 24 horas

RSS Error: A feed could not be found at https://www.gov.uk/government/topical-events/coronavirus-covid-19-uk-government-response.atom. A feed with an invalid mime type may fall victim to this error, or SimplePie was unable to auto-discover it.. Use force_feed() if you are certain this URL is a real feed.

Risolto uno dei misteri delle pietre di Stonehenge
Perché il cromosoma Y non si è (ancora) estinto
Foreste d'Italia, bellezza e silenzio nel lockdown
Modificare gli ormoni delle piante per migliorare la produzione di cibo
In compagnia dei giganti

HEALTH A-Z

IMMUNOLOGY

Covid 19

CANCER

Difference Between Polycythemia and Erythrocytosis

HIV

Integrase inhibitors give greater chance of viral suppression in pregnant women

Covid 19

What are the treatments for addiction?

CBD

FDA Authorizes First Standalone At-Home Sample Collection Kit